Incyte (INCY) Revenue (QoQ) (2010 - 2026)
Incyte (INCY) Revenue (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 473.74 Bn | 468.95 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.07 Bn | 114.82 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.00 Bn | 61.24 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Incyte | 23.71 Bn | 19.69 Bn | 1.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.54% |
| Dec 31, 2025 | 10.31% |
| Sep 30, 2025 | 12.38% |
| Jun 30, 2025 | 15.45% |
| Mar 31, 2025 | -10.67% |
| Dec 31, 2024 | 3.59% |
| Sep 30, 2024 | 9.02% |
| Jun 30, 2024 | 18.49% |
| Mar 31, 2024 | -13.07% |
| Dec 31, 2023 | 10.26% |
| Sep 30, 2023 | -3.73% |
| Jun 30, 2023 | 18.05% |
| Mar 31, 2023 | -12.74% |
| Dec 31, 2022 | 12.56% |
| Sep 30, 2022 | -9.67% |
| Jun 30, 2022 | 24.30% |
| Mar 31, 2022 | -15.02% |
| Dec 31, 2021 | 6.13% |
| Sep 30, 2021 | 15.20% |
| Jun 30, 2021 | 16.70% |